Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week low during trading on Monday. The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 10,591 shares changing hands. The stock had previously closed at C$0.07.
MediPharm Labs Stock Down 7.7%
The firm’s 50-day moving average price is C$0.07 and its 200 day moving average price is C$0.07. The company has a current ratio of 2.66, a quick ratio of 3.10 and a debt-to-equity ratio of 0.90. The company has a market capitalization of C$25.63 million, a price-to-earnings ratio of -6.00 and a beta of -0.60.
MediPharm Labs Company Profile
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
See Also
- Five stocks we like better than MediPharm Labs
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
